Fibrin-selective thrombolytic therapy for acute myocardial infarction

被引：80

作者：

Collen, D ^{[1
]}

机构：

[1] CATHOLIC UNIV LEUVEN VIB, CTR TRANSGENE TECHNOL & GENE THERAPY, B-3000 LOUVAIN, BELGIUM

来源：

关键词：

bench to bedside; fibrin; myocardial infarction; thrombolysis;

D O I：

10.1161/01.CIR.93.5.857

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：857 / 865

页数：9

共 89 条

[1]

ANDERSON HV, 1993, NEW ENGL J MED, V329, P703

[2]

[Anonymous], 1995, Lancet, V346, P329

[3]

[Anonymous], 1986, LANCET, V1, P397

[4] FIBRINOLYSIS - PAST AND PRESENT, A REFLECTION OF 50 YEARS [J].

ASTRUP, T .

[5]

BECKER RC, 1994, MODERN ERA CORONARY

BEHNKE, D ;

GERLACH, D .

MOLECULAR & GENERAL GENETICS, 1987, 210 (03) :528-534

[7]

BERGMANN SR, 1983, SCIENCE, V220, P1181

[8] THE OPEN-ARTERY THEORY IS ALIVE AND WELL - AGAIN [J].

BRAUNWALD, E .

[9]

BRAUNWALD E, 1992, J AM COLL CARDIOL, V19, P1116, DOI 10.1016/0735-1097(92)90306-8

[10]

CHAZOV EI, 1976, TERAPEVT ARKH, V48, P8